Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L LaBelle

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|October 29, 2002
Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemiaJames L LaBelle, Robert L Truitt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Stem cell transplant as an immunomodulatory tool for children with hematologic malignanciesJames L LaBelle, John M Cunningham
Current Treatment Options in Oncology|June 7, 2021
Current Status of CAR T Cell Therapy for LeukemiasKatherine Harris, James L LaBelle, Michael R Bishop
Advanced Healthcare Materials|March 14, 2022
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and ProteinsYu Tian, Matthew V Tirrell, James L LaBelle
Pediatric Annals|July 15, 2015
Diagnostic Criteria and Evaluation of Severe Combined Immunodeficiency in the NeonateCarrie E Diamond, Matthew J Sanchez, James L LaBelle
Methods in Molecular Biology (Clifton, N.J.)|December 12, 2018
Flow Cytometry-Based Detection and Analysis of BCL-2 Family Proteins and Mitochondrial Outer Membrane Permeabilization (MOMP)Lindsey M Ludwig, Katrina L Maxcy, James L LaBelle
Frontiers in Pediatrics|January 10, 2017
Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune ModulationLindsey M Ludwig, Michele L Nassin, Abbas Hadji, et al.
Blood|March 6, 2002
Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemiaJames L LaBelle, Carrie A Hanke, Bruce R Blazar, et al.
ACS Omega|November 10, 2018
Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester HydrolysisMathew R Schnorenberg, Sang Pil Yoo, Matthew V Tirrell, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 30, 2020
Loss of BIM in T cells results in BCL-2 family BH3-member compensation but incomplete cell death sensitivity normalizationLindsey M Ludwig, Lauren E Roach, Samuel G Katz, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|October 29, 2002
Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemiaJames L LaBelle, Robert L Truitt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Stem cell transplant as an immunomodulatory tool for children with hematologic malignanciesJames L LaBelle, John M Cunningham
Current Treatment Options in Oncology|June 7, 2021
Current Status of CAR T Cell Therapy for LeukemiasKatherine Harris, James L LaBelle, Michael R Bishop
Advanced Healthcare Materials|March 14, 2022
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and ProteinsYu Tian, Matthew V Tirrell, James L LaBelle
Pediatric Annals|July 15, 2015
Diagnostic Criteria and Evaluation of Severe Combined Immunodeficiency in the NeonateCarrie E Diamond, Matthew J Sanchez, James L LaBelle
Methods in Molecular Biology (Clifton, N.J.)|December 12, 2018
Flow Cytometry-Based Detection and Analysis of BCL-2 Family Proteins and Mitochondrial Outer Membrane Permeabilization (MOMP)Lindsey M Ludwig, Katrina L Maxcy, James L LaBelle
Frontiers in Pediatrics|January 10, 2017
Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune ModulationLindsey M Ludwig, Michele L Nassin, Abbas Hadji, et al.
Blood|March 6, 2002
Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemiaJames L LaBelle, Carrie A Hanke, Bruce R Blazar, et al.
ACS Omega|November 10, 2018
Synthesis and Purification of Homogeneous Lipid-Based Peptide Nanocarriers by Overcoming Phospholipid Ester HydrolysisMathew R Schnorenberg, Sang Pil Yoo, Matthew V Tirrell, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 30, 2020
Loss of BIM in T cells results in BCL-2 family BH3-member compensation but incomplete cell death sensitivity normalizationLindsey M Ludwig, Lauren E Roach, Samuel G Katz, et al.
Pageof 5